Tecsys Reports $50M Q1 Revenue as SaaS Growth Boosts Profits

Tecsys reported $50.0 million in revenue for the first quarter of fiscal 2027, marking a 9% year-over-year increase. The company's shift toward its Elite SaaS platform contributed to a 306% rise in net profit, which reached $3.1 million. These results indicate a move toward AI-enabled supply chain management, specifically within the healthcare sector.

"We are not seeing anyone buy our latest platform without buying TecsysIQ," said Peter Brereton, CEO of Tecsys, regarding the integration of the company's artificial intelligence tools into customer workflows.

SaaS Performance and Market Penetration

SaaS revenue reached $22.7 million during the quarter, an 18% increase compared to the same period last year. Growth was led by the Elite SaaS platform, which saw a 24% year-over-year rise. Demand in the healthcare industry drove this performance, as the sector accounts for 83% of the company's total SaaS annual recurring revenue.

Management highlighted a $1.6 billion total addressable market opportunity within U.S. health systems. By embedding TecsysIQ, the company's proprietary AI layer, into its core offerings, the firm intends to capture a larger share of the inventory and logistics management needs found in hospital operations.

Record Bookings and Outlook

Executive leadership pointed to pipeline development as an indicator for the remainder of the fiscal year.

"We are delivering record bookings, in fact, the second highest bookings quarter Tecsys has ever recorded, giving us real momentum and visibility as we head into the rest of the year," said Brereton.

What Is at Stake

For Tecsys, the transition from legacy software delivery to a SaaS model is necessary to stabilize recurring revenue and expand operating margins. As health systems face pressure to modernize supply chain logistics to reduce waste and optimize clinical inventory, the adoption of AI-enabled platforms has become a requirement. The company's ability to maintain its current SaaS growth trajectory depends on its success in scaling these implementations across U.S. healthcare providers.